Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PIWIL2 divergent transcript (PIWIL2-DT) is a non-protein-coding RNA annotated in the PIWIL2 locus, representing a transcript that originates in a direction divergent from the canonical PIWIL2 protein-coding transcript[3]. There is limited published information about PIWIL2-DT itself; most literature focuses on either PIWIL2 protein or other PIWIL2-related non-coding transcripts that may regulate gene expression through epigenetic mechanisms. PIWIL2 protein has established roles in cancer biology, specifically tumor cell proliferation and apoptosis, through regulation of TGF-β signaling and the unfolded protein response[1][2]. PIWIL2-DT's unique transcript and genomic annotation position suggest potential regulatory functions, but this remains largely unexplored. If more targeted information about PIWIL2-DT is required, additional experimental and bioinformatic studies are needed to clarify its precise function and therapeutic relevance[3].
Not applicable, as no therapeutic agents specifically target PIWIL2-DT.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PIWIL2 divergent transcript (PIWIL2-DT).